Lv51
1130 积分 2022-07-20 加入
The ENHANCE-3 study: venetoclax and azacitidine plus magrolimab or placebo for untreated AML unfit for intensive therapy
2分钟前
待确认
Azacitidine–Venetoclax or Induction Chemotherapy for Acute Myeloid Leukemia
3分钟前
待确认
A randomized phase 2 study combining midostaurin, low-dose cytarabine and venetoclax in newly diagnosed AML ≥60 years
5分钟前
待确认
Homoharringtonine Added to Venetoclax and Azacitidine Improves Outcome and Mitigates Genetic Impact in Relapsed/Refractory AML: A Multicenter Cohort Study
7分钟前
待确认
Dapk2 dysfunction leads to Mic60 lactylation and mitochondrial metabolic reprogramming, promoting lung cancer EGFR-TKI resistance and metastasis
2个月前
已完结
Lactylation Converts ABHD6 into a Mitochondrial Regulator that Drives Lenvatinib Resistance in Hepatocellular Carcinoma
2个月前
已完结
Acquired resistance to venetoclax plus azacitidine in acute myeloid leukemia: In vitro models and mechanisms
3个月前
已完结
Integrative Genomics Identifies the Molecular Basis of Resistance to Azacitidine Therapy in Myelodysplastic Syndromes
4个月前
已完结
Luspatercept (RAP-536) modulates oxidative stress without affecting mutation burden in myelodysplastic syndromes
4个月前
已完结
Genetic subtypes of B-cell acute lymphoblastic leukemia in adults
10个月前
已完结